Services / Cancer Care / Research / Clinical Trials /

Clinical Trial

« Back to List

LUN 225

Posted by: Fred J. Kudrik, MD, Principal Investigator | Posted Date: December 31, 2012

Status: OPEN - IST
Research Hotline: 803-461-3708

Details: A Phase 1/2 Study to Assess the Safety and Efficacy of Lorvotuzumab Mertansine (IMGN901) in Combination with Carboplatin/Etoposide in Patients with Advanced Solid Tumors including Extensive Stage Small Cell Lung Cancer.

This clinical trial is being offered at the following location: South Carolina Oncology Associates


Bookmark and Share